Impact of EGFR and KRAS mutations on clinical outcomes in previously untreated patients with advanced NSCLC treated with gefitinib or erlotinib: Results of an online tumor registry of clinical trials Meeting Abstract
| Authors: | Jackman, D. M.; Miller, V. A.; Cioffredi, L. A.; Yeap, B. Y.; Jänne, P. A.; Riely, G. J.; Ruiz, M. G.; Giaccone, G.; Sequist, L. V.; Johnson, B. E. |
| Abstract Title: | Impact of EGFR and KRAS mutations on clinical outcomes in previously untreated patients with advanced NSCLC treated with gefitinib or erlotinib: Results of an online tumor registry of clinical trials |
| Meeting Title: | 13th World Conference on Lung Cancer (IASLC) |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 4 |
| Issue: | 9 Suppl. 1 |
| Meeting Dates: | 2009 Jul 31-Aug 4 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2009-01-01 |
| Start Page: | S349 |
| End Page: | S350 |
| Language: | English |
| ACCESSION: | ISI:000269496001075 |
| PROVIDER: | wos |
| PUBMED: | 19704333 |
| DOI: | 10.1097/JTO.0b013e3181b9c77e |
| Notes: | --- - Meeting Abstract B9.2 - Suppl. 1 - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work